Senescence suppressors: Their practical importance in replicative lifespan extension in stem cells

Cellular and Molecular Life Sciences

Volumn 71, Issue 21, 2014, Pages 4207-4219

  Hwang, Eun Seong ^a  

^a University of Seoul   (South Korea)

Author keywords

Differentiation; ECM; Mesenchymal stem cell (MSC); Replicative lifespan extension; Replicative senescence; Stem cell therapy

Indexed keywords

ATORVASTATIN; BILIVERDIN REDUCTASE A; COMPACTIN; HEME OXYGENASE 1; KLOTHO PROTEIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRION PROTEIN; PROTEASOME; PROTEIN 20S; PROTEIN 26S; PROTEIN P53; RETINOBLASTOMA PROTEIN; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ANTIOXIDANT; BETA GLUCURONIDASE; NFE2L2 PROTEIN, HUMAN; PRION; SIRT1 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG MECHANISM; EMBRYONIC STEM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SENESCENCE; STEM CELL EXPANSION; TRANSCRIPTION INITIATION; ANIMAL; CELL AGING; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRION; STEM CELL;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; CELL ADHESION; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; GLUCURONIDASE; HUMANS; MESENCHYMAL STROMAL CELLS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRIONS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIRTUIN 1; STEM CELLS;

EID: 84922009762     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1685-1     Document Type: Review

References (186)

1. Banfi A, Muraglia A, Dozin B et al (2000) Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28:707-715
2. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294
3. Ringdén O, Uzunel M, Rasmusson I et al (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397
4. Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926
5. Tokalov SV, Gruener S, Schindler S et al (2007) A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol Cells 24:255-260
6. Rombouts WJ, Ploemacher RE (2003) Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17:160-170
7. Digirolamo CM, Stokes D, Colter D et al (1999) Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281
8. Sethe S, Scutt A, Stolzing A (2006) Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116
9. Honczarenko M, Le Y, Swierkowski M et al (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041
10. Brohlin M, Kingham PJ, Novikova LN et al (2012) Aging effect on neurotrophic activity of human mesenchymal stem cells. PLoS One 7:e45052
11. Gruber HE, Somayaji S, Riley F et al (2012) Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence. Biotech Histochem 87:303-311
12. Erickson IE, van Veen SC, Sengupta S et al (2011) Cartilage matrix formation by bovine mesenchymal stem cells in three-dimensional culture is age-dependent. Clin Orthop Relat Res 469:2744-2753
13. Stolzing A, Jones E, McGonagle D, Scutt A (2008) Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129:163-173
14. Janzen V, Forkert R, Fleming HE et al (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443:421-426
15. Molofsky AV, Slutsky SG, Joseph NM et al (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443:448-452
16. von Zglinicki T, Martin-Ruiz C, Saretzki G (2005) Telomeres, cell senescence and human ageing. Signal Transduct 3:103-114
17. Hwang ES (2002) Replicative senescence and senescence-like state induced in cancer-derived cells. Mech Ageing Dev 123:1681-1694
18. Helmbold H, Galderisi U, Bohn W (2012) The switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence. J Cell Physiol 227:508-513
19. Alessio N, Bohn W, Rauchberger V et al (2013) Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells. Cell Mol Life Sci 70:1637-1651
20. Hutter E, Unterluggauer H, Uberall F et al (2002) Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress. Exp Gerontol 37:1165-11674
21. Ozawa T (1997) Genetic and functional changes in mitochondria associated with aging. Physiol Rev 77:425-464
22. 2 concentration extends the life span of cultured human diploid cells. Nature 267:423-425
23. 2 tension on the in vitro-replicative life span of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res 217:272-279
24. Estrada JC, Albo C, Benguría A et al (2012) Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 19:743-755
25. Cowell JK (1990) The nuclear oncoproteins: RB and p53. Semin Cancer Biol 1:437-446
26. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89-116
27. Kapeta S, Chondrogianni N, Gonos ES (2010) Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 285:8171-8184
28. Kwak MK, Wakabayashi N, Greenlaw JL et al (2003) Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23:8786-8794
29. Li J, Johnson D, Calkins M et al (2005) Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci 83:313-328
30. Haneline LS (2008) Redox regulation of stem and progenitor cells. Antioxid Redox Signal 10:1849-1852
31. Lu L, Song HF, Zhang WG et al (2012) Potential role of 20S proteasome in maintaining stem cell integrity of human bone marrow stromal cells in prolonged culture expansion. Biochem Biophys Res Commun 422:121-127
32. Dröge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6:361-370
33. Milani P, Ambrosi G, Gammoh O et al (2013) SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxid Med Cell Longev 2013:836760
34. Barbagallo I, Galvano F, Frigiola A et al (2013) Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal 18:507-521
35. Su ZY, Shu L, Khor TO et al (2013) A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics. Top Curr Chem 329:133-162
36. Davies KJ (2003) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301-310
37. Demasi M, Davies KJ (2003) Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism. FEBS Lett 542:89-94
38. Grune T, Merker K, Sandig G, Davies KJ (2003) Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305:709-718
39. Lehman NL (2009) The ubiquitin proteasome system in neuropathology. Acta Neuropathol 118:329-347
40. Bulteau AL, Petropoulos I, Friguet B (2000) Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35:767-777
41. Chondrogianni N, Stratford FL, Trougakos IP et al (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 278:28026-28037
42. Hwang JS, Hwang JS, Chang I, Kim S (2007) Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. J Gerontol A Biol Sci Med Sci 62:490-499
43. Chondrogianni N, Gonos ES (2004) Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology 5:55-61
44. Adams J, Palombella VJ, Sausville EA et al (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59:2615-2622
45. Chapple SJ, Siow RC, Mann GE (2012) Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol 44:1315-1320
46. Lavu S, Boss O, Elliott PJ, Lambert PD (2008) Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7:841-853
47. Park S, Mori R, Shimokawa I (2013) Do sirtuins promote mammalian longevity?: A Critical review on its relevance to the longevity effect induced by calorie restriction. Mol Cells 35:474-480
48. Saunders LR, Sharma AD, Tawney J et al (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging 2:415-431
49. Sasaki T, Maier B, Bartke A, Scrable H (2006) Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5:413-422
50. Huang J, Gan Q, Han L et al (2008) SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One 3:e1710
51. Yuan HF, Zhai C, Yan XL et al (2012) SIRT1 is required for long-term growth of human mesenchymal stem cells. J Mol Med (Berl) 90:389-400
52. Peng CH, Chang YL, Kao CL et al (2010) SirT1-a sensor for monitoring self-renewal and aging process in retinal stem cells. Sensors (Basel) 10:6172-6194
53. Langley E, Pearson M, Faretta M et al (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21:2383-2396
54. Han MK, Song EK, Guo Y et al (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2:241-251
55. Vaziri H, Dessain SK, Ng Eaton E et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159
56. Luo J, Nikolaev AY, Imai S et al (2001) Negative control of p53 by Sir2alpha pro Nemoto motes cell survival under stress. Cell 107:137-148
57. Ota H, Akishita M, Eto M et al (2007) Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 43:571-579
58. Menssen A, Hydbring P, Kapelle K et al (2012) The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci USA 109:E187-E196
59. Palacios JA, Herranz D, De Bonis ML et al (2010) SIRT1 contributes to telomere maintenance and augments global homologous recombination. J Cell Biol 191:1299-1313
60. Zhang Y, Chen L, Yang S, Fang D (2012) E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc. Med Sci Monit 18:RA12-RA15
61. Yamashita S, Ogawa K, Ikei T et al (2012) SIRT1 prevents replicative senescence of normal human umbilical cord fibroblast through potentiating the transcription of human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 417:630-634
62. Olmos Y, Sánchez-Gómez FJ, Wild B et al (2013) SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex. Antioxid Redox Signal 19:1507-1521
63. Yao H, Sundar IK, Ahmad T et al (2014) SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 306:L816-L828
64. Lee IH, Cao L, Mostoslavsky R et al (2008) A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 105:3374-3379
65. Kume S, Uzu T, Horiike K et al (2010) Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 120:1043-1055
66. Chua KF, Mostoslavsky R, Lombard DB et al (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67-76
67. Chen X, Barton LF, Chi Y et al (2007) Ubiquitin-independent degradation of cell-cycle inhibitors by the REGγ proteasome. Mol Cell 26:843-852
68. Lin T, Chao C, Saito S et al (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7:165-171
69. Verma-Kurvari S, Savage T, Gowan K, Johnson JE (1996) Lineage-specific regulation of the neural differentiation gene MASH1. Dev Biol 180:605-617
70. Prozorovski T, Schulze-Topphoff U, Glumm R et al (2008) Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 10:385-394
71. Libert S, Cohen D, Guarente L (2008) Neurogenesis directed by Sirt1. Nat Cell Biol 10:373-374
72. Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430
73. Bitterman KJ, Anderson RM, Cohen HY et al (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem. 277:45099-45107
74. Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013
75. van der Veer E, Ho C, O'Neil C et al (2007) Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 282:10841-10845
76. Ho C, van der Veer E, Akawi O, Pickering JG (2009) SIRT1 markedly extends replicative lifespan if the NAD + salvage pathway is enhanced. FEBS Lett 583:3081-3085
77. Kang HT, Hwang ES (2009) Nicotinamide enhances mitochondria quality through autophagy activation in human cells. Aging Cell 8:426-438
78. Jang SY, Kang HT, Hwang ES (2012) Nicotinamide-induced mitophagy: event mediated by high NAD +/NADH ratio and SIRT1 protein activation. J Biol Chem 287:19304-19314
79. Schmeisser K, Mansfeld J, Kuhlow D et al (2013) Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol 9:693-700
80. Kamat JP, Devasagayam TP (1999) Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria. Redox Rep 4:179-184
81. Kuro-o M, Matsumura Y, Aizawa H et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51
82. Kurosu H, Ogawa Y, Miyoshi M et al (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281(10):6120-6123
83. Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774
84. Liu F, Wu S, Ren H, Gu J (2011) Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 13:254-262
85. Kuilman T, Michaloglou C, Vredeveld LC et al (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019-1031
86. de Oliveira RM (2006) Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett 580:5753-5758
87. Kikuchi G, Yoshida T, Noguchi M (2005) Heme oxygenase and heme degradation. Biochem Biophys Res Commun 338:558-567
88. Piantadosi CA, Withers CM, Bartz RR et al (2011) Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J Biol Chem 286:16374-16385
89. Guillen MI, Megias J, Gomar F, Alcaraz MJ (2008) Heme oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes. J Pathol 214:515-522
90. Garcia-Arnandis I, Guillen MI, Castejon MA et al (2010) Heme oxygenase-1 down-regulates high mobility group box 1 and matrix metalloproteinases in osteoarthritic synoviocytes. Rheumatology 49:854-861
91. Barbagallo I, Vanella A, Peterson SJ et al (2010) Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab 28:276-288
92. Clérigues V, Guillén MI, Castejón MA et al (2012) Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts. Biochem Pharmacol 83:395-405
93. Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093-16098
94. Tudor C, Lerner-Marmarosh N, Engelborghs Y et al (2008) Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. Biochem J 413:405-416
95. Barone E, Di Domenico F, Sultana R et al (2012) Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52:2292-2301
96. Kim SY, Park SC (2012) Physiological antioxidative network of the bilirubin system in aging and age-related diseases. Front Pharmacol 3:45
97. Kim SY, Kang HT, Choi HR, Park SC (2011) Biliverdin reductase A in the prevention of cellular senescence against oxidative stress. Exp Mol Med 43:15-23
98. Alam J, Cook JL (2003) Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 9:2499-2511
99. Diep QN, Amiri F, Touyz RM et al (2002) PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40:866-871
100. Tao L, Liu HR, Gao E et al (2003) Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation 108:2805-2811
101. Umeji K, Umemoto S, Itoh S et al (2006) Cu/Zn superoxide dismutase, PPAR-gamma, and aortic stiffness in hypercholesterolemia. Am J Physiol Heart Circ Physiol 291:H2522-H2532
102. Zhang H, Li Y, Fan Y et al (2008) Klotho is a target gene of PPAR-gamma. Kidney Int 74:732-739
103. Ricote M, Glass CK (2007) PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771:926-935
104. Nicolakakis N, Aboulkassim T, Ongali B et al (2008) Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J Neurosci 28:9287-9296
105. Briganti S, Flori E, Mastrofrancesco A et al (2013) Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ. Exp Dermatol 22:41-47
106. Kim HJ, Ham SA, Paek KS et al (2011) Transcriptional up-regulation of antioxidant genes by PPARδ inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells. Biochem Biophys Res Commun 406:564-569
107. Kim HJ, Ham SA, Kim SU et al (2008) Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Circ Res 102:193-200
108. Lim HA, Lee EK, Kim JM et al (2012) PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney. Biogerontology 13:133-145
109. Kim HJ, Ham SA, Kim MY et al (2011) PPARδ coordinates angiotensin II-induced senescence in vascular smooth muscle cells through PTEN-mediated inhibition of superoxide generation. J Biol Chem 286:44585-44593
110. Ham SA, Hwang JS, Yoo T et al (2012) Ligand-activated PPARδ inhibits UVB-induced senescence of human keratinocytes via PTEN-mediated inhibition of superoxide production. Biochem J 444:27-38
111. Kim MY, Kang ES, Ham SA et al (2012) The PPARδ-mediated inhibition of angiotensin II-induced premature senescence in human endothelial cells is SIRT1-dependent. Biochem Pharmacol 84:1627-1634
112. Chen LJ, Cheng MF, Ku PM (2014) Lin JW (2014) Rosiglitazone increases cerebral klotho expression to reverse baroreflex in type 1-like diabetic rats. Biomed Res Int 2014(309151):13. doi: 10.1155/2014/309151.Epub
113. Yang HC, Deleuze S, Zuo Y et al (2009) The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol 20:2380-2388
114. Zhang T, Wang F, Xu HX et al (2013) Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Br J Nutr 109:223-235
115. Cho HY, Gladwell W, Wang X et al (2010) Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med 182:170-182
116. Steele AD, Emsley JG, Ozdinler PH et al (2006) Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci USA 103:3416-3421
117. Chakraborty C, Nandi S, Jana S (2005) Prion disease: a deadly disease for protein misfolding. Current Pharmaceutical Biotechnology 6:167-177
118. Mohanty ST, Cairney CJ, Chantry AD et al (2012) A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID mice. Stem Cells 30:1134-1143
119. Brown DR, Besinger A (1998) Prion protein expression and superoxide dismutase activity. Biochem J 334:423-429
120. Brown DR, Wong BS, Hafiz F et al (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem J 344(Pt 1):1-5
121. Malaisé M, Schätzl HM, Bürkle A (2008) The octarepeat region of prion protein, but not the TM1 domain, is important for the antioxidant effect of prion protein. Free Radic Biol Med 45:1622-1630
122. Kramer ML, Kratzin HD, Schmidt B et al (2001) Prion protein binds copper within the physiological concentration range. J Biol Chem 276:16711-16719
123. Rachidi W, Vilette D, Guiraud P et al (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278:9064-9072
124. Thompson MJ, Borsenberger V, Louth JC et al (2009) Design, synthesis, and structure-activity relationship of indole-3-glyoxylamide libraries possessing highly potent activity in a cell line model of prion disease. J Med Chem 52:7503-7511
125. Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600
126. Kawamoto A, Gwon HC, Iwaguro H et al (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634-637
127. Llevadot J, Murasawa S, Kureishi Y et al (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108:399-405
128. Kureishi Y, Luo Z, Shiojima I et al (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes agiogenesis in normocholesterolemic animals. Nat Med 6:1004-1010
129. Assmus B, Urbich C, Aicher A et al (2003) HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92:1049-1055
130. Breitschopf K, Zeiher AM, Dimmeler S (2001) Proatherosclerotic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 493:21-25
131. Dimmeler S, Aicher A, Vasa M et al (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108:391-397
132. Chandramohan V, Jeay S, Pianetti S, Sonenshein GE (2004) Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels. J Immunol 172:5522-5527
133. Wassmann S, Laufs U, Bäumer AT et al (2001) HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37:1450-1457
134. Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 22:300-305
135. Ota H, Eto M, Kano MR et al (2010) Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 30:2205-2211
136. Sung B, Park S, Yu BP, Chung HY (2004) Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci. 59:997-1006
137. Zhu JH, Chen JZ, Wang XX et al (2006) Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells. J Mol Cell Cardiol 40:648-652
138. Guterres FA, Martinez GR, Rocha ME, Winnischofer SM (2013) Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway. Exp Cell Res 319:2977-2988
139. Lindner U, Kramer J, Behrends J et al (2010) Improved proliferation and differentiation capacity of human mesenchymal stromal cells cultured with basement-membrane extracellular matrix proteins. Cytotherapy 12(8):992-1005
140. Lai Y, Sun Y, Skinner CM et al (2010) Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev 19:1095-1107
141. Liu X, Yin D, Zhang Y et al (2007) Vascular endothelial cell senescence mediated by integrin beta4 in vitro. FEBS Lett 581:5337-5342
142. Sun C, Liu X, Qi L et al (2010) Modulation of vascular endothelial cell senescence by integrin β4. J Cell Physiol 225:673-681
143. Sun Y, Li W, Lu Z et al (2011) Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J 25:1474-1485
144. Pioletti DP, Takei H, Lin T et al (2000) The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials 21:1103-1114
145. Choi HR, Cho KA, Kang HT et al (2011) Restoration of senescent human diploid fibroblasts by modulation of the extracellular matrix. Aging Cell 10:148-157
146. de la Serna IL, Ohkawa Y, Imbalzano AN (2006) Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7:461-473
147. Alessio N, Squillaro T, Cipollaro M et al (2010) The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 29:5452-5463
148. Nemoto S, Fergusson MM, Finkel T (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306:2105-2108
149. Chang TC, Wentzel EA, Kent OA et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752
150. Yamakuchi M (2012) MicroRNA regulation of SIRT1. Front Physiolo. doi: 10.3389/fphys.2012.00068
151. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M (2008) miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. U.S.A. 105:20297-20302
152. Abdelmohsen K, Pullmann R Jr, Lal A et al (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25:543-557
153. Chen J, Xavier S, Moskowitz-Kassai E et al (2012) Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol 180:973-983
154. Park JH, Yi HW, DiMaio D, Hwang ES (2008) Heterogeneous upregulation of lysosomal genes in human fibroblasts and cancer cells undergoing senescence. Korean J Genet 29:521-527
155. Caito S, Rajendrasozhan S, Cook S et al (2010) SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 24:3145-3159
156. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260
157. Molofsky AV, He S, Bydon M et al (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19:1432-1437
158. Jacobs JJ, Kieboom K, Marino S et al (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-168
159. Itahana K, Zou Y, Itahana Y et al (2003) Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 23:389-401
160. Wang Y, Guan Y, Wang F et al (2010) Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro. Neurosci Lett 476(2):74-78
161. He S, Iwashita T, Buchstaller J et al (2009) Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo. Dev Biol 328:257-272
162. Dimri GP, Martinez JL, Jacobs JJ et al (2002) The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62:4736-4745
163. Zhang X, Soda Y, Takahashi K et al (2006) Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochem Biophys Res Commun 351:853-859
164. Jacobs JJ, Scheijen B, Voncken JW et al (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13:2678-2690
165. Jiang L, Li J, Song L (2009) Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 41:527-534
166. Bulavin DV, Demidov ON, Saito S et al (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31:210-215
167. Bulavin DV, Phillips C, Nannenga B et al (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36:343-350
168. Lee JS, Lee MO, Moon BH et al (2009) Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways. Stem Cells 27:1963-1975
169. Cha BH, Lee JS, Kim SW et al (2013) The modulation of the oxidative stress response in chondrocytes by Wip1 and its effect on senescence and dedifferentiation during in vitro expansion. Biomaterials 34:2380-2388
170. Rossi DJ, Jamieson CH, Weissman IL (2008) Stems cells and the pathways to aging and cancer. Cell 132:681-696
171. Parrinello S, Samper E, Krtolica A et al (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5:741-747
172. Dröge W (2002) Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37:1333-1345
173. Giles GI (2006) The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 12:4427-4443
174. Simonsen JL, Rosada C, Serakinci N et al (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20(6):592-596
175. Abdallah BM, Haack-Sørensen M, Burns JS et al (2005) Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite extensive proliferation. Biochem Biophys Res Commun 326(3):527-538
176. Liang XJ, Chen XJ, Yang DH et al (2012) Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro. Cell Biol Int 36(2):215-221
177. Stroikin Y, Dalen H, Brunk UT, Terman A (2005) Testing the "garbage" accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy. Biogerontology 6:39-47
178. Giordano S, Darley-Usmar V, Zhang J (2013) Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol 2:82-90
179. Hubbard BP, Sinclair DA (2014) Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci 35:146-154
180. Pacholec M, Bleasdale JE, Chrunyk B et al (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285:8340-8351
181. Fox RJ, Kita M, Cohan SL et al (2014) BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety. Curr Med Res Opin 30:251-262
182. Suh JH, Shenvi SV, Dixon BM et al (2004) Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 101:3381-3386
183. Lii CK, Liu KL, Cheng YP et al (2010) Sulforaphane and alpha-lipoic acid upregulate the expression of the pi class of glutathione S-transferase through c-jun and Nrf2 activation. J Nutr 140:885-892
184. Zhao XD, Zhou YT, Lu XJ (2013) Sulforaphane enhances the activity of the Nrf2-ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells. Inflamm Res 62:857-863
185. Dinkova-Kostova AT, Liby KT, Stephenson KK et al (2005) Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA 102:4584-4589
186. Kiemer AK, Bildner N, Weber NC, Vollmar AM (2003) Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144:802-812